$IPSC
Century Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Century Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is IPSC down today? It is at $1.16 (-11.74%), and our scanner flagged it 83 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment IPSC spikes, and full due diligence on IPSC — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $IPSC 83 times in the last 30 days. Create a free account to track $IPSC, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
The market is closed. Here is how IPSC traded in the last session, Friday (last price and move above). Our scanner fired 13 unusual-volume and momentum alerts on IPSC on Friday, peaking at 65.5x its normal volume. A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
Likely catalystCentury Therapeutics Reports Third Quarter 2026 Financial Results and Business UpdatesReported Cash runway into 1Q 2029 with cash, cash equivalents, and investments of $174.1 million as of September 30, 2026Reported General and Administrative (G&A) Expenses: G&A expenses were $7.1 million for the quarter ended September 30, 2026, compared to $6.8 million for the same period in 2025.Reported Net Loss: Net loss was $23.5 million for the quarter ended September 30, 2026, compared to a net loss of $34.4 million for the same period in 2025., from an SEC filing. Read it →Latest filing4Insider trade (Form 4)Nov 17, 2026 · 4 days agoAcross every filing on file, supply equal to 4682.8% of the tradeable float is in play - 4682.8% has already been sold.
One filing exceeds the whole float, which usually means our share count is stale. Check the filing directly.
Recent priced share offering — a one-time sale that has already completed (not ongoing)
506,915,533 new shares
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Pfeiffenberger Brent Officer | Sold (automatic/other) | -31K 0.02% of company | sold 0.9% | 3.60M | $51K at $1.65 | Nov 13, 26 |
Carr Douglas Officer | Sold (automatic/other) | -266 | sold <0.1% | 503K | $404 at $1.52 | Nov 3, 26 |
Carr Douglas Officer | Sold (automatic/other) | -2K | sold 0.3% | 503K | $3K at $1.93 | Sep 14, 26 |
Russotti Gregory Officer | Sold (automatic/other) | -3K | sold 0.5% | 509K | $5K at $1.93 | Sep 14, 26 |
Pfeiffenberger Brent Officer | Sold (automatic/other) | -14K | sold 0.4% | 3.63M | $27K at $1.94 | Sep 11, 26 |
Carr Douglas Officer | Sold (automatic/other) | -254 | sold <0.1% | 505K | $521 at $2.05 | Sep 8, 26 |
Russotti Gregory Officer | Sold (automatic/other) | -534 | sold 0.1% | 512K | $1K at $2.05 | Sep 8, 26 |
Pfeiffenberger Brent Officer | Sold (automatic/other) | -463 | sold <0.1% | 3.63M | $977 at $2.11 | Sep 4, 26 |
Pfeiffenberger Brent Officer | Sold (automatic/other) | -31K 0.02% of company | sold 0.9% | 3.63M | $60K at $1.92 | Aug 14, 26 |
Carr Douglas Officer | Sold (automatic/other) | -275 | sold <0.1% | 505K | $545 at $1.98 | Aug 3, 26 |
Carr Douglas Officer | Sold (automatic/other) | -2K | sold 0.3% | 505K | $4K at $2.23 | Jun 12, 26 |
Russotti Gregory Officer | Sold (automatic/other) | -3K | sold 0.5% | 512K | $6K at $2.23 | Jun 12, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in biological products, (no diagnostic substances), closest in size first.
The market is closed. Here is how IPSC traded in the last session, Friday (last price and move above). Our scanner fired 13 unusual-volume and momentum alerts on IPSC on Friday, peaking at 65.5x its normal volume. A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
IPSC last traded at $1.16, down 11.74% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The IPSC Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged IPSC 83 times in the last 30 days.
IPSC (Century Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $212M in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge IPSC for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$IPSC discussion
Sign in to ask a question or join the discussion.